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Malaria parasite transmission requires differentiation of male and female gametocytes into gametes within a mosquito
following a blood meal. A mosquito-derived molecule, xanthurenic acid (XA), can trigger gametogenesis, but the
signalling events controlling this process in the human malaria parasite Plasmodium falciparum remain unknown. A
role for cGMP was revealed by our observation that zaprinast (an inhibitor of phosphodiesterases that hydrolyse
cGMP) stimulates gametogenesis in the absence of XA. Using cGMP-dependent protein kinase (PKG) inhibitors in
conjunction with transgenic parasites expressing an inhibitor-insensitive mutant PKG enzyme, we demonstrate that
PKG is essential for XA- and zaprinast-induced gametogenesis. Furthermore, we show that intracellular calcium (Ca2þ)
is required for differentiation and acts downstream of or in parallel with PKG activation. This work defines a key role
for PKG in gametogenesis, elucidates the hierarchy of signalling events governing this process in P. falciparum, and
demonstrates the feasibility of selective inhibition of a crucial regulator of the malaria parasite life cycle.
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Introduction
Plasmodium falciparum is the causative agent of the most
lethal form of malaria, thought to kill over a million people
each year. Malaria pathology is caused by proliferation of
asexual blood stage parasites, whereas transmission is
mediated by an obligatory sexual life cycle phase. Gamete
precursors (gametocytes) develop from asexual blood stage
parasites and are thought to sequester by binding to
endothelium cells. After 8–10 d, they reenter the circulation
and must be taken up by a female Anophelesmosquito during a
blood meal to continue the life cycle. Prior to activation,
mature P. falciparum gametocytes are crescent-shaped, but
differentiate to become spherical (known as ‘‘rounding up’’)
upon entering the insect midgut. Gametogenesis is stimulated
in vitro by a temperature decrease, coupled with either a rise
in pH [1,2] or the presence of a mosquito-derived factor [3],
xanthurenic acid (XA) [4,5]. Both sexes must emerge from
host erythrocytes prior to fertilisation. It is crucial to the
success of transmission that gametocytes remain inactivated
in the human host, yet respond immediately once inside the
mosquito midgut. Upon activation, male gametocytes under-
go a series of spectacular changes, including three rounds of
genome replication and mitotic division, resulting in the
release of eight highly motile, ﬂagellated gametes within only
10 min [6,7]. Observation of this process (known as
exﬂagellation) by Laveran in 1880 was one of the ﬁrst major
clues that malaria was caused by a parasitic protozoan [8]. In
the rodent malaria parasite Plasmodium berghei, XA triggers an
intracellular rise in Ca2þ concentration, which is required for
gametogenesis. A Ca2þ-dependent protein kinase (CDPK4) is
known to mediate some of the effects of XA in P. berghei male
gametocytes, where it is essential for the initiation of DNA
replication [9]. Evidence that other second messengers may
be involved in controlling this process has been reported. The
products of phosphatidylinositol hydrolysis by phospholipase
C have been implicated in exﬂagellation [10,11], and the use
of pharmacological agents has provided evidence of a role for
cGMP [12]. In eukaryotes, intracellular levels of cGMP are
generally balanced by the opposing action of synthetic
(guanylyl cyclase [GC]) and hydrolytic (phosphodiesterase
[PDE]) enzymes. The P. falciparum genome contains two genes
encoding biochemically active, membrane-associated GCs
that are expressed in gametocytes. Each has a C-terminal,
paired catalytic domain reminiscent of mammalian G
protein-dependent adenylyl cyclases and an N-terminal P-
type ATPase-like domain [13]. It has been observed that
addition of XA to mature P. falciparum gametocyte membrane
preparations elevated GC activity [14]. There are four genes
encoding putative cyclic nucleotide PDEs in the P. falciparum
genome, and their expression at the mRNA level is
developmentally regulated [15]. A single cGMP-dependent
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protein kinase (PKG) enzyme is present in the parasite, which
has some structural and biochemical properties unique to
apicomplexan parasites [16–18]. In P. falciparum, the gene is
expressed in both the asexual and sexual blood stages of the
life cycle [16,19]. PKG mediates numerous cellular processes
in diverse eukaryotes, ranging from changes in behavioural
patterns in bees [20] to penile smooth muscle relaxation in
mammals [21]. In the present study, we aimed to investigate
the role of PKG in P. falciparum sexual development. We have
used a genetic approach combined with speciﬁc inhibitors to
show conclusively that in P. falciparum, PKG is essential for
mediating initiation of gametogenesis, and we provide
evidence that the enzyme may be activated in a narrow
temporal window prior to Ca2þ signalling.
Results
The cGMP-PDE Inhibitor Zaprinast Can Stimulate P.
falciparum Gametogenesis in the Absence of XA
As an initial step in evaluating the potential role of cGMP
in P. falciparum sexual stage development, we tested a number
of inhibitors on PDE activity in parasite particulate fractions.
We found that widely used PDE inhibitors, such as caffeine,
IBMX, and theophylline, had little or no effect when tested on
native PDE enzyme activity (see Table S1). In contrast,
zaprinast, a speciﬁc cGMP-PDE inhibitor reported to
interfere with asexual parasite growth [22], was an effective
inhibitor (a 50% inhibitory concentration [IC50] of 33.7 6 1.3
lM for gametocytes and 3.0 6 1.2 lM for schizonts; Table S1).
Importantly, when tested on live gametocytes, zaprinast
stimulated rounding up in the absence of XA (Figure 1A).
Zaprinast triggered both rounding up and exﬂagellation in a
dose-dependent manner (Figure 1B and 1C), suggesting that
increased intracellular cGMP levels play a role in this process.
Nuclear enlargement and ﬂagella formation, both character-
istic of activated male gametocytes, were visualised by
immunoﬂuorescence analysis (IFA) (Figure 1D) and trans-
mission electron microscopy (tEM) (Figure 1E) after stim-
ulation with either XA or zaprinast. IFA with an anti–a-
tubulin monoclonal antibody (Figure 1D) revealed a charac-
teristic pattern of strong peripheral labelling of assembled
axonemes, and transverse sections of the axonemes were also
visible in electron micrographs (Figure 1E). Only a subpopu-
lation of gametocytes was labelled by the anti–a-tubulin
antibody, which may reﬂect a higher concentration of tubulin
in male gametocytes. Taken together, these observations
imply that in P. falciparum, zaprinast-induced increases in
cytosolic cGMP levels can trigger gametogenesis and its
constituent events.
The Membrane-Permeable Ca2þ Chelator BAPTA-AM
Inhibits Exflagellation, but Not Rounding Up, of P.
falciparum Gametocytes
In the rodent malaria parasite P. berghei, cytosolic Ca2þ is
mobilised within 10 s of gametocyte activation, and functions
as a key second messenger for gamete egress, male cell cycle
progression, and exﬂagellation [9]. We therefore examined
the role of Ca2þ in P. falciparum gametogenesis activated by
either XA or zaprinast. As with P. berghei, pretreatment of
gametocytes with the membrane-permeable Ca2þ chelator,
BAPTA-AM, blocked exﬂagellation (Figure 2A, lower panel)
and reduced emergence of gametes from erythrocytes (Figure
2B). Gamete emergence was measured by IFA using an anti-
human erythrocyte Band 3 monoclonal antibody that served
as a marker for the presence of erythrocyte membrane
around gametes. Zaprinast did not overcome the Ca2þ
requirement for exﬂagellation (Figure 2A, lower panel),
suggesting it acts upstream of Ca2þ. Interestingly, BAPTA-
AM failed to inhibit the rounding up of gametocytes
following stimulation by either zaprinast or XA (Figure 2A,
upper panel), indicating that this dramatic change in cellular
morphology characteristic of P. falciparum gametocyte activa-
tion, might be Ca2þ independent and regulated through
cGMP alone.
The Anticoccidial PKG Inhibitor Compound 1 Arrests
Rounding Up of Gametocytes and Exflagellation
Scrutiny of the P. falciparum genome for potential media-
tors of cGMP, gave no obvious matches with genes encoding
cyclic nucleotide-gated ion channels, but we and others have
previously identiﬁed a single functional PKG (PfPKG) ex-
pressed in both asexual and sexual blood stage parasites
[16,19]. We hypothesised that PfPKG could be the primary
intracellular effector of cGMP in malaria parasites. We found
that the PfPKG gene is refractory to deletion, suggesting that
it is essential in the asexual blood stage parasites (L.
McRobert and D. A. Baker, unpublished data). An alternative
genetic approach was therefore used for functional analysis.
As a ﬁrst step in this strategy, we tested the effect of the
trisubstituted pyrrole (4-[2-(ﬂuorophenyl)-5-(1-methylpiperi-
dine-4-yl)-1H pyrrol-3-yl] pyridine), compound 1, a highly
speciﬁc ATP-competitive inhibitor of PKG in the related
coccidian parasites Eimeria and Toxoplasma [18], on P.
falciparum. Compound 1 inhibited the growth of asexual
blood stages (IC50 2.70 6 0.17 lM; unpublished data) at a level
similar to previous ﬁndings [19]. We then tested the effect of
the compound on gametogenesis. Importantly, compound 1
inhibited rounding up, with gametocytes clearly retaining
their distinctive crescent shape (Figure 3A, left panel). By
contrast, gametocytes treated with XA alone became spher-
ical (Figure 3A, right panel) indicating that gametogenesis
had been initiated. Both rounding up and exﬂagellation of P.
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Author Summary
The protozoan parasite Plasmodium falciparum, which causes
malaria in humans, is responsible for over 1 million deaths each
year. Its life cycle is complex; the asexually replicating forms, which
cause disease symptoms, are quite distinct from the sexual forms,
which mediate transmission between individuals via the bite of a
mosquito. After a period of growth in the human host, these sexual
forms (gametocytes) lie dormant until taken up by a mosquito. The
change in environment from human to mosquito triggers differ-
entiation into mature gametes. In this study, we have identified a
protein kinase from the parasite that is instrumental in mediating
this essential differentiation step. We have also gained insight into
how this protein kinase might interact with calcium to coordinate
these events. By using genetically modified malaria parasites in
combination with specific inhibitors of the protein kinase, we have
illustrated the feasibility of blocking development of the sexual
stage of the parasite’s life cycle. Development of a drug that targets
this parasite stage, for use in combination with a curative drug,
would be an important tool for controlling the spread of drug
resistance.
falciparum gametocytes were inhibited by compound 1 in a
dose-dependent manner (Figure 3B and 3C).
Substitution of a Key Active Site Threonine Residue
Confers Compound 1 Insensitivity to Recombinant PfPKG
Compound 1, like most ATP-competitive inhibitors, has
the potential to inhibit more than one protein kinase in the
cell. To verify the speciﬁcity of compound 1, we followed a
strategy used with coccidian PKGs [23] involving replacement
of a key threonine residue (Figure 4A) with an amino acid
with a bulky side chain to confer inhibitor insensitivity to the
parasite. This substitution, critically, did not affect other
aspects of biochemical activity of the coccidian enzymes and
allowed unambiguous identiﬁcation of the cellular events in
which PKG plays a vital role. To investigate whether
refractory forms of PfPKG could be engineered, we generated
two alternative mutant enzymes following site-directed muta-
Figure 2. Intracellular Ca2þ Is Not Required for the Initial Step of P.
falciparum Gametogenesis
To investigate the role of intracellular Ca2þ in rounding up and
exflagellation, stage V Pfrh3 control gametocytes were pretreated with
the BAPTA-AM (BP) before stimulation of gametogenesis with either XA
or zaprinast (ZP).
(A) (Upper panel) Gametocytes were scored as either round or crescent-
shaped, and plotted as percentage rounded-up. Results show the means
of duplicate counts, and error bars indicate mean 6 SEM. (Lower panel)
The number of centres of exflagellation per 10,000 gametocytes was
scored. Results show the means of duplicate counts and error bars
indicate mean 6 SEM.
(B) Emergence from host erythrocytes before and after stimulation of
gametogenesis with or without BAPTA-AM was scored using IFA with an
anti-erythrocyte Band 3 monoclonal antibody. The proportion of cells
not reacting with the antibody (indicative of complete emergence) was
counted and plotted as a percentage. Results show the means from
quadruplicate counts from two independent experiments, and error bars
indicate mean 6 SEM.
doi:10.1371/journal.pbio.0060139.g002
Figure 1. Zaprinast Can Stimulate Rounding Up and Exflagellation of
Mature Gametocytes in the Absence of XA
Zaprinast was added to mature gametocytes to assess the effects on
gametogenesis compared to XA. The concentration of XA used was 20
lM, and the concentration of zaprinast was 400 lM, unless stated
otherwise.
(A) Micrographs of Giemsa-stained Stage V gametocytes prior to
stimulation of gametogenesis (left panel) and after addition of XA
(centre panel) or zaprinast (right panel). The scale bar indicates 10 lm.
(B) Increasing concentrations of zaprinast were added to stimulate
gametogenesis, and cells were scored as either round or crescent-
shaped, and plotted as a percentage rounded-up. Results are based on
triplicate counts of a representative experiment from the same flask of
gametocytes on a single day (except for 12.5 and 25 lM, which are based
on a single count only). Error bars indicate the standard error of the
mean (6 SEM). The experiment was carried out twice with very similar
results.
(C) The number of centres of exflagellation per 10,000 gametocytes was
scored following addition of increasing concentrations of zaprinast.
Results are based on triplicate counts of a representative experiment
from the same flask of gametocytes on a single day. Error bars indicate
mean 6 SEM. The experiment was carried out twice with very similar
results.
(D) Merged confocal images of Giemsa-stained stage V gametocytes
prior to stimulation of gametogenesis (left panel) and after addition of
XA (centre panel) or zaprinast (right panel). Blue indicates DAPI-stained
nuclei and red the anti-a tubulin antibody (Tat1) staining of cells. The
scale bars indicate 5 lm.
(E) Transmission electron micrographs of male or female gametocytes
after stimulation of gametogenesis with XA (left and centre panels) or
zaprinast (right panel). a, axonemes; m, mitochondrion; N, nucleus. Scale
bars indicate 0.5 lm.
doi:10.1371/journal.pbio.0060139.g001
PLoS Biology | www.plosbiology.org June 2008 | Volume 6 | Issue 6 | e1391245
Malaria Parasite PKG and Gametogenesis
genesis. PfPKGT618 was replaced with either glutamine or
methionine, and expressed in Escherichia coli. Compound 1 was
found to be a potent inhibitor of the wild-type (WT)
recombinant enzyme (IC50 value was 5.796 0.89 nM), whereas
the mutant PfPKG harbouring the glutamine residue
(PfPKGT618Q) was over 3,000 times less sensitive at 17.8 6
4.7 lM (Figure 4B). This single amino acid substitution
therefore confers compound 1 insensitivity to the recombi-
nant protein. There was an unexpected (by analogy with the
coccidian enzymes) decrease in IC50 value (1.55 6 0.62 nM)
with the mutant PKG containing M618 (PfPKGT618M) (Figure
4B), indicating that this amino acid substitution did not
confer insensitivity to compound 1 in the context of the
recombinant P. falciparum protein expressed in E. coli. It has
been observed previously that mutation of the equivalent
amino acid position (the ‘‘gatekeeper residue’’) in other
protein kinases can lead to unpredictable properties.
Instability or even complete loss of catalytic activity has been
observed, depending on the residue introduced [24]. Both
mutant enzymes were therefore generated in parallel to
increase the chance of obtaining a compound 1–insensitive
kinase. The results indicate that only the T618Q substitution
conferred a high degree of insensitivity to compound 1 and
that its introduction into the parasite might facilitate
identiﬁcation of cellular processes in which PfPKG plays an
essential role.
Transgenic P. falciparum Gametocytes Expressing an
Inhibitor-Insensitive PKG Can Round Up Normally in the
Presence of Compound 1 and Compound 2 Following
Stimulation by Either XA or Zaprinast
Compound 1–resistant P. falciparum parasites were then
generated using an allelic replacement strategy. Asexual 3D7
ring stage parasites were transfected according to standard
procedures using the pHH1 plasmid in conjunction with the
antifolate WR99210 for drug selection [25]. Genotype analysis
conﬁrmed that a single crossover homologous recombination
had occurred, introducing the desired nucleotide substitu-
tion into the PfPKG gene downstream of its own promoter
(Figure S1). In the absence of compound 1, the mutant and
control cell lines had equivalent properties in terms of their
rates of asexual replication (Figure S2) and gametocyte
development, conﬁrming that the mutant PKG was fully
functional. An approximately 2-fold increase in the expres-
Figure 3. Compound 1 Inhibits Gametogenesis at Its Onset
To investigate the effect of compound 1 on gametogenesis, stage V
Pfrh3 gametocytes were induced with and without compound 1.
(A) Light micrographs of XA-stimulated gametocytes in the presence (left
panel) or absence (right panel) of 2 lM compound 1. The size bar
indicates 5 lm.
(B) Increasing concentrations of compound 1 were added with XA (or
without XA, Con), and cells were scored as either round or crescent-
shaped, and plotted as percentage rounded up. Results are based on
duplicate counts from a representative experiment, and error bars
indicate mean 6 SEM. The results of this experiment have been
reproduced on more than ten occasions.
(C) The number of centres of exflagellation per 10,000 gametocytes was
scored. Results are based on duplicate counts from a representative
experiment, and error bars indicate mean 6 SEM.
doi:10.1371/journal.pbio.0060139.g003
Figure 4. Substitution of a Key Active Site Threonine Residue Confers Compound 1 Insensitivity to Recombinant PfPKG
(A) An alignment of regions of PfPKG in the ATP-binding pocket, thought to interact with compound 1, with those of other apicomplexans. Conserved
active site residues highlighted in grey were predicted to approach compound 1 in a model of the Eimeria tenella PKG [29] (EtPKG). The threonine
residue (T618), substituted in PfPKG in this study, is highlighted in grey and marked with an asterisk. Amino acid sequences are numbered to the right
of the blocks of sequence.
(B) Dose-response curves showing the effect of compound 1 on recombinant PKG enzyme activity assayed in the presence of 10 lM cGMP. Red
diamonds indicate full-length WT PfPKG; black triangles, mutated PfPKG with T618 replaced by a glutamine residue; and blue squares, mutated PfPKG
with T618 replaced by a methionine residue. IC50 values (6 SEM): WT 5.8 6 0.91 nM; T618Q mutant 17,800 6 4,700 nM; and T618M mutant 1.5 6 0.61
nM.
doi:10.1371/journal.pbio.0060139.g004
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sion level (possibly due to the presence of a heterologous 39
untranslated region following allelic replacement) of PfPKG
in activated PfPKGT618Q gametocyte preparations was meas-
ured in western blots, but cGMP-dependent kinase activity
levels were equivalent in mutant and control lines (Figure
5A). The difference in PKG band intensity obtained in
western blots between life cycle stages probably reﬂects a
higher level of PKG expression in gametocytes compared to
rings, but the higher speciﬁc activity in rings is reproducible.
However, the purpose of this ﬁgure is to provide conﬁrma-
tion that PKG activity levels measured in control and mutant
clones were similar at a given life cycle stage.
In a key experiment, the mutant cell lines were tested for
their ability to round-up in the presence of compound 1.
Addition of 1–5 lM compound 1 to control gametocytes
reduced rounding up to background levels. Crucially, we
observed that gametocytes from PfPKGT618Q clones rounded
up to almost normal levels in the presence of 1–5 lM
compound 1 after stimulation with XA (Figure 5B). These
data conﬁrm that expression of PfPKGT618Q in mutant
parasites reduces their sensitivity to compound 1. The results
show clearly that PfPKG is the primary target of compound 1
during initiation of differentiation and demonstrate that this
enzyme plays an essential role in stimulating gametogenesis.
We obtained similar results using a second inhibitor (the
imidazopyridine, 4-[7-[(dimethylamino)methyl]-2-(4-ﬂuoro-
phenyl)imidazo[1,2-a]pyridine-3-yl]pyrimidin-2-amine, com-
pound 2 [26]) (Figure 5C), conﬁrming an essential role for
PfPKG in gametogenesis. Furthermore, the absence of
inhibitory effects of compound 1 and compound 2 upon
stimulation of PfPKGT618Q gametocytes with either zaprinast
or XA (Figure 5C) indicates that the ability of both
compounds to trigger gametogenesis is PKG dependent.
Measurements of rounding up using a range of concen-
trations of compound 1 and 2 showed that PfPKGT618Q
gametocytes had an approximately 10–20-fold lower sensi-
tivity to the inhibitors than control cells. IFA and tEM
analysis revealed that the compound 1–treated control cells
showed no evidence of DNA synthesis (enlarged male nuclei),
axoneme formation, or emergence from red cells and thus
resembled unstimulated gametocytes. This conﬁrms that
inhibition of PfPKG blocks gametogenesis at its onset.
Although we were able to measure cGMP-dependent kinase
activity in cell lysates, we were unable to observe any
differential compound 1 sensitivity in this activity between
control and mutant lysates. Both had equivalent levels of
sensitivity to compound 1. A likely explanation is that the
cGMP-dependent activity measured in lysates includes a
PKG-activated, compound 1–sensitive downstream kinase
activity, with the result that the difference in compound 1
sensitivity of PKG itself between the two cell lines is masked.
This is consistent with our observation that although both
compound 1 and 2 inhibited exﬂagellation in a dose-
dependent manner, there was no signiﬁcant difference in
sensitivity to either compound measured in control and
PfPKGT618Q cell lines in terms of inhibition of exﬂagellation
levels (unpublished data). This suggests that the compounds
may inhibit additional protein kinases (downstream of PKG)
that are required for other constituent events of exﬂagella-
tion, but not for rounding up. Candidates include members
of the CDPK family [26].
A cloned line of PfPKGT618M was also generated and tested
for the effects of compound 1 on rounding up and
exﬂagellation. The relatively small (,4-fold) increase in
sensitivity to compound 1 that was unexpectedly observed
in the recombinant enzyme was not reﬂected in the parasite.
There was no signiﬁcant difference in sensitivity to com-
pound 1 compared to control cells, conﬁrming that the
T618M substitution did not confer insensitivity to compound
1. By contrast, the greatly decreased sensitivity to compound
1 conferred by the T618Q mutant (.3,000-fold in the
recombinant protein) was reﬂected in a highly signiﬁcant
(analysed by Poisson Regression with Stata 9.2; StataCorp)
decrease in inhibitor sensitivity in the parasite. Therefore,
only the T618Q mutant proved to be a useful tool for
functional studies. Analysis of rounding up in the presence of
Figure 5. Transgenic P. falciparum Expressing an Inhibitor-Insensitive
PfPKG Demonstrate an Essential Role for the Enzyme in the Initiation of
Gametogenesis
(A) Native cGMP-dependent kinase activity in independent clones of
PfPKGT618Q mutants (A and B) and the Pfrh3
 (Psu) control cells were
measured in both ring stage parasites and activated gametocytes in the
presence of 10 lM cGMP. At least two independent experiments were
carried out in triplicate, and the data displayed are from a representative
experiment (error bars indicate mean 6 SEM). A western blot of each
sample is shown beneath, incubated with an anti-human PKGIa
antibody. Lanes contain approximately 2 3 108 ring stage parasites or
23 106 activated gametocytes. One quarter of these amounts was used
in native PKG assays. A recombinant, N-terminally truncated PfPKG (87
kDa) is included as a positive control (Con). Equivalent loading was
assessed by reprobing the blot with the anti–a-tubulin antibody Tat-1.
(B) Compound 1 (1 lM, 2 lM, and 5 lM) was added along with XA to WT
(grey bars) and PfPKGT618Q (clone A) gametocytes (white bars); cells were
scored as either round or crescent-shaped, and plotted as percentage
rounded-up. Results show data from duplicate counts from a represen-
tative experiment, and error bars indicate mean 6 SEM.
(C) Quantification of rounding up upon stimulation of WT (grey bars) and
PfPKGT618Q (clone A) gametocytes (white bars) with either XA or
zaprinast (ZP) in the presence of either 2 lM compound 1 (C1) or 2
lM compound 2 (C2). Results show data from duplicate counts from a
representative experiment, and error bars indicate mean 6 SEM.
doi:10.1371/journal.pbio.0060139.g005
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varying compound 1 concentration (0.1–20 lM) from
replicate experiments for both mutants compared to WT is
presented in Figure S3 and Table S2.
The combined results of this study indicate that PfPKG is
essential for the Ca2þ-independent differentiation of P.
falciparum gametocytes from crescent-shaped to spherical,
whereas Ca2þ is required for other constituent events of
gametogenesis including exﬂagellation (Figure 6).
Discussion
As Plasmodium gametocytes transit from the mammalian
blood stream to the mosquito midgut, they encounter a
radically distinct environment. Gametogenesis is triggered
rapidly in response to signals in the new environment so that
fertilisation can proceed. The molecular details, however, of
how reduced temperature might combine with XA or pH
changes to bring about differentiation are largely unknown.
In this study, we have demonstrated a role for cGMP and PKG
in the initiation of gametogenesis by XA in P. falciparum. We
have further concluded that although Ca2þ is also essential for
this process, it is possible that activation of PKG may precede
Ca2þ in the hierarchy of signalling events.
A Role for cGMP in Regulating Differentiation
We found that PDE inhibitors previously reported to
promote small increases in exﬂagellation in Plasmodium
[12,27] did not inhibit P. falciparum native PDE activity,
whereas zaprinast (a speciﬁc cGMP-PDE inhibitor) was
effective in the mid micromolar range. Zaprinast (400 lM)
induced both rounding up of gametocytes and exﬂagellation
at levels almost equivalent to those triggered by XA,
suggesting that increases in endogenous cGMP levels could
indeed stimulate exﬂagellation as previously reported [12].
Zaprinast has previously been demonstrated to effectively
inhibit PDEs from Trypanosoma brucei [28] and a P. falciparum
PDE expressed during the asexual life cycle stages [22]. The
insensitivity of the protozoan PDEs to several potent
inhibitors of mammalian PDEs probably reﬂects subtle
differences in the enzyme active sites.
Our results show that the underlying cellular events that
accompany XA-induced rounding up also take place upon
addition of zaprinast and thus conﬁrm the speciﬁcity of the
morphological change. Furthermore, the validity of the
rounding up stimulated by zaprinast was veriﬁed unequiv-
ocally by the fact the male gametocytes were able to
exﬂagellate. The speciﬁcity of zaprinast on the cGMP pathway
was conﬁrmed when used in combination with mutant cell
lines expressing a PKG allele conferring reduced sensitivity to
inhibitors (see below).
PKG Is Essential for the Initiation of Gametogenesis in P.
falciparum
Since the parasite PKG proved refractory to deletion, we
generated an inhibitor-insensitive mutant line of P. falciparum
by allelic replacement for functional studies. A similar
approach was used previously to determine the role of PKG
Figure 6. A Schematic Representing the Progression of Gametogenesis and the Proposed Hierarchy of Signalling Events That Occur
P. falciparum gametogenesis can be stimulated in vitro by addition of XA or zaprinast combined with a decrease in temperature. Within 2 min, a
profound morphological change occurs whereby both male and female gametocytes transform from crescent-shaped to spherical. This process can still
take place upon chelation of intracellular Ca2þ with BAPTA-AM, but gamete emergence is reduced and exflagellation is completely inhibited. By
contrast, the primary rounding-up step (and subsequent progression) is completely halted by specific inhibition of the parasite PKG. This protein kinase
therefore plays an essential role in mediating the initiation of gametogenesis, and it may act upstream of or in parallel with Ca2þ signalling. The
involvement of CDPK4 in this process has been demonstrated for P. berghei.
doi:10.1371/journal.pbio.0060139.g006
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in related coccidian parasites [23]. The strategy relies on a key
threonine residue found in apicomplexan PKGs (but few
other protein kinases) that forms the basis of selectivity of the
ﬂuorophenyl group of compounds 1 and 2. Replacement of
the threonine with an alternative residue containing a bulky
side chain is thought to prevent access of the inhibitors to a
binding pocket that overlaps the ATP-binding site and
thereby confers insensitivity to the compound [26,29]. A key
point is that in the absence of inhibitors, the PfPKGQ618
mutant clones behaved normally in terms of asexual
replication and sexual development. Levels of rounding up
and exﬂagellation were also indistinguishable from WT
parasites, suggesting that the mutant PKG is fully functional.
This also conﬁrms that there have been no adverse effects due
to the genetic modiﬁcation itself. Upon addition of com-
pounds 1 and 2, dramatic differences between control
parasites and mutants were noted in terms of their ability
to round up following stimulation by either XA or zaprinast.
We conclude that PKG is the primary target of the
compounds and that PKG activity is essential for the
initiation of gametogenesis. This also demonstrates that the
effects of XA and zaprinast are PKG dependent and supports
the view that XA, cGMP, and PKG are all components of the
same gametocyte activation pathway in P. falciparum. Differ-
ences between control and mutant parasite lines in their
sensitivity to compounds 1 and 2 during exﬂagellation,
however, were not pronounced. This suggests that other
protein kinases, sensitive to compounds 1 and 2, may be
functional as exﬂagellation proceeds. A potential candidate is
the P. falciparum ortholog of PbCDPK4, the Ca2þ-dependent
protein kinase essential for exﬂagellation in P. berghei [9]. In
support of this hypothesis, it is of note that the CDPK4
ortholog from Toxoplasma and Eimeria (designated CDPK1) is a
secondary target of compound 2 [26]. PfCDPK4 has a serine
residue at the key position that is potentially compatible with
inhibitor sensitivity.
Intracellular Ca2þ Is Required for Exflagellation, but Not
Rounding Up, of P. falciparum Gametocytes
We used the membrane-permeable Ca2þ chelator BAPTA-
AM to show that, as with P. berghei [9], intracellular Ca2þ is
essential for exﬂagellation in P. falciparum. However, it is clear
that rounding up, an early event during P. falciparum
gametogenesis, which requires PKG, is not sensitive to
inhibition by BAPTA-AM. Cellular Ca2þ is therefore not
essential for PKG activation and thus cannot be the key
upstream regulator. By contrast, this step is sensitive to
speciﬁc PKG inhibitors and is therefore PKG dependent. The
early events in P. falciparum gametogenesis mediated by PKG
are assumed to occur in both sexes, because compound 1
prevents the change of shape in over 90% of gametocytes,
therefore likely reﬂecting a population of both males and
females. In P. berghei, it has been shown that BAPTA-AM can
block all the constituent events of both male and female
gametogenesis, indicating that they are Ca2þ dependent [9]. It
is therefore unclear whether the Ca2þ-independent nature of
P. falciparum rounding up represents a species-speciﬁc differ-
ence or whether it reﬂects the fact that rounding up in P.
berghei is not such a morphologically distinguishable event
since the crescent shape, characteristic of P. falciparum
gametocytes, is lacking in rodent malarias.
Our observation that in P. falciparum constituent events of
gametogenesis, that are Ca2þ dependent, can be triggered
effectively by the PDE inhibitor zaprinast alone, would be
consistent with a hierarchical second messenger cascade in
which the cGMP effector PKG functions as a master switch
during gametocyte activation that acts upstream of Ca2þ
mobilisation. However, alternative models in which Ca2þ and
cGMP have parallel functions cannot currently be ruled out.
Interestingly, crosstalk between both second messenger
pathways has been suggested to regulate other aspects of
apicomplexan biology, gliding motility, and invasion in
Toxoplasma gondii.
All constituent events of gametocyte activation in P.
falciparum and P. berghei require gametocytes to be exposed
to two coinciding stimuli, one of which must be a drop in
temperature, the other can be XA or a rise in extracellular
pH [1–5]. The mobilisation of cellular Ca2þ in P. berghei occurs
approximately 10 s after gametocytes have been exposed to
activating conditions [9]. A cGMP-dependent signalling
pathway operating upstream of calcium mobilisation would
thus have to become active within 10 s. It may either serve to
integrate the different activating stimuli or may only be
initiated once these have been integrated by unknown
receptor mechanisms. How, at the molecular level, Ca2þ and
cGMP-dependent signalling pathways may be linked to each
other and to upstream activators remains unknown, which is
true also of the GC and PDEs that control the cGMP level in
gametocytes. It is clear, however, that downstream of the
initial activation, different Ca2þ- and cGMP-dependent
effectors are required to drive gametocyte differentiation.
Combined evidence from P. berghei and P. falciparum suggests
that at least three such effector pathways exist: (1) a PKG-
dependent, Ca2þ-independent pathway that mediates round-
ing up of P. falciparum gametocytes; (2) a Ca2þ-dependent
pathway (which may also be PKG dependent) that initiates
cell cycle progression in microgametocytes through CDPK4
[9]; and (3) a calcium-dependent pathway (which may also
require PKG) that regulates CDPK4-independent constituent
events, such as emergence, in gametocytes of either sex [9].
PKG Plays Numerous Important Roles in Diverse
Organisms
A role for PKG in secretion of adhesins required for gliding
motility and host cell invasion in Eimeria sporozoites and
Toxoplasma tachyzoites has been demonstrated [23]. Interest-
ingly, a role for cGMP in P. berghei ookinete gliding motility
has been suggested following deletion of a GC gene (PbGCb) in
P. berghei [30]. Deletion of this gene had no measurable effect
on gametogenesis in the rodent malaria parasite, which is
consistent with our results following disruption of PfGCb in P.
falciparum [31]. However, a second structurally related GC
gene expressed in P. falciparum gametocytes [13] may provide
functional redundancy. Interestingly, disruption of a P.
falciparum cGMP-PDE gene (PfPDEd) that is highly up-
regulated in gametocytes leads to prematurely high intra-
cellular cGMP levels and a greatly reduced ability to undergo
gametogenesis [31], suggesting that regulation of cGMP levels,
particularly at the level of its breakdown, is important for
normal gametogenesis.
A number of physiological roles have been identiﬁed for
PKG in the organisms studied to date. In the single-cell alga
Chlamydomonas, PKG has a key role in the signalling events
induced by ﬂagellar adhesion via interaction of surface
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agglutinins during fertilisation [32,33]. PKG is involved in
changes in patterns of foraging behaviour in insects such as
Drosophila [34], bees [20], and ants [35], and also in the
nematode Caenorhabditis elegans [36]. One of the mammalian
PKG isoforms (cGKI) is found in a number of tissue types,
including all smooth muscles. The association of PKG
function and Ca2þ levels in smooth muscle tone has been
the subject of intense study [37]. Mammalian PKG also plays a
key role in penile smooth muscle relaxation and has been
shown to phosphorylate a number of Ca2þ-binding proteins
involved in this process [21].
Our demonstration that PfPKG has a crucial role in
regulating gametogenesis in P. falciparum now provides a
framework for identifying the downstream proteins involved
in differentiation. It will be intriguing to compare the PKG
substrates that mediate the underlying events of gameto-
genesis in Plasmodium with those that mediate parasite
invasion and egress in other apicomplexans in which PKG
plays a role. Compounds 1 and 2 are prototype inhibitors of
apicomplexan PKG which have been shown to cure chickens
of Eimeria infection and mice of infection by T. gondii.
Compound 1 also delays the onset of P. berghei infections in
mice [18,19,26]. Our data predict that in addition to targeting
asexual erythrocytic stages, a drug inhibiting Plasmodium PKG
could also block parasite transmission to the mosquito, a
highly desirable property that would help limit the spread of
any drug-resistant parasites. Transmission-blocking drugs
would be a powerful tool for reducing the malaria burden
in areas endemic for P. falciparum.
Materials and Methods
All reagents were from Sigma-Aldrich unless otherwise stated.
Cell culture and gametogenesis assays. P. falciparum gametocytes
were produced from the 3D7 clone in human Aþ erythrocytes with
10% human serum (National Blood Service), and enriched using
Nycodenz (Nycoprep 1.077; Axis-Shield) centrifugation as previously
described [38]. For gametogenesis, cells were resuspended at 53 106
parasites per millilitre and induced with either 20 lM XA or 25–400
lM zaprinast in complete medium, and a reduction (of .5 8C) in
temperature. For gametogenesis assays, 10 min post induction, cells
were mounted on a wet smear. Rounding up was observed for a total
of 200 cells, and exﬂagellation for a total of 10,000 cells over 10 min.
Test reagents including zaprinast, BAPTA-AM, compound 1, and
compound 2 were resuspended in DMSO as stock solutions and
diluted in complete medium for gametogenesis assays, with the XA
stock resuspended in RPMI 1640. The maximum ﬁnal DMSO
concentration in the gametogenesis medium was 0.4%, which was
used as a negative control. Negative control cells were exposed to
medium that was at exactly the same temperature as the test cells, but
no rounding up or exﬂagellation was seen in the negative controls.
Compound 1 and compound 2 were added at the point of activation
with either XA or zaprinast, whereas cells were preincubated with 100
lM BAPTA-AM as previously described [9]. Statistical multivariate
analysis was carried out using Poisson regression (Stata 9.2;
StataCorp) to compare the effects of genetic background (mutant
vs. WT) and experimental replicate (included as categorical data in
the analysis) on the rates of rounding up at individual drug
concentrations. For each drug concentration, the mutants were
tested separately against the WT control, and the resultant output
was anti-logged to give the relative risk (and 95% conﬁdence interval)
for rounding up with genetic background.
Transfection. Allelic replacement of PfPKG was performed using
standard transfection techniques [25]. Constructs based on the pHH1
plasmid were produced as follows: The hsp86 59 region was excised
from pHH1 using XhoI and BglII, and replaced with the 1.7-kb 39
fragment of PfPKG (amino acids [aa] 286–853) mutated at the T618
position to either methionine or glutamine [17]; see Figure S1 for
further details. Asexual ring stage parasites were transfected with
either pHH1-PKG-M or pHH1-PKG-Q. The presence of human
dihydrofolate reductase selectable marker in the plasmids allowed
selection of integrants with on/off drug cycling with the antifolate
WR99210 (10 nM). Parasites were cloned by limiting dilution prior to
genotype veriﬁcation by Southern analysis and PCR. A 3D7-derived
Pfrh3 KO line, used as a control, was generated using the pHHTK
plasmid as previously described [39]. This cell line had been in culture
for the same length of time and under the same conditions as the
mutant cell lines. It was indistinguishable from WT in terms of
asexual and sexual growth and development.
IFA and tEM analysis. For IFA, 3 3 106 mature P. falciparum
gametocytes were ﬁxed in paraformaldehyde according to a method
used for P. berghei [40]. Cells were washed thoroughly and allowed to
settle on wells coated with 0.01% poly-L-lysine solution. Primary
antibodies, either mouse anti–a-tubulin (Tat-1; a gift from Keith Gull,
University of Oxford) or mouse monoclonal anti-Band 3 (Abcam)
were used at a concentration of 1:50, followed by a 1:10,000 dilution
of Alexa Fluor 594 goat anti-mouse IgG (Molecular Probes).
Vectashield (Vector Laboratories) containing DAPI allowed the cells
to be visualised using a Zeiss Axovert LSM 510 confocal microscope.
Images were captured using LSM 510 software (Carl Zeiss Micro-
Imaging). For tEM, 108 erythrocytes (at 5%–10% gametocytaemia)
were ﬁxed in 2.5% glutaraldehyde/2% paraformaldehyde [41] after
induction of gametogenesis by XA or zaprinast. Pellets were treated
with 1% osmium tetroxide and embedded in TAAB hard resin. Ultra-
thin resin sections were stained with Reynolds lead citrate and
examined on a Jeol 1200EX Mark II transmission electron microscope
at 80 kV. Digital images were recorded using a side-mounted 1K 1.3M
pixel High Sensitivity AMT Advantage ER CCD camera system.
Growth inhibition assays. Asexual parasite growth assays were
carried out to obtain the IC50 of test compounds using inhibition of
incorporation of [3H]-hypoxanthine [42], and to compare growth
rates between transfected clones. Brieﬂy, in 96-well plates, each test
well was dosed at early trophozoite stage with 10 ll of [3H]-
hypoxanthine (GE Healthcare) to a ﬁnal concentration of 0.2 lCi.
The radioactivity of the [3H]-hypoxanthine incorporated into para-
site nucleic acid over 24 h was determined relative to the WT controls
using a Wallac 1450 Microbeta scintillation b-counter (Perkin-Elmer).
This assay was done in triplicate and repeated at least three times.
PKG activity assay. The activity of recombinant and native PKG
was measured using a modiﬁcation of standard procedures [18,19].
The gene encoding full-length PfPKG was cloned into the pTrcHis
expression plasmid (Invitrogen). Substitution of speciﬁc amino acids
of PfPKG was carried out using a QuickChange Multi Site-Directed
Mutagenesis kit (Stratagene) according to the manufacturer’s
instructions. Expression, afﬁnity puriﬁcation of E. coli–expressed
recombinant proteins, and PKG activity assays were performed as
previously described [17]. All experiments were performed at least
twice in triplicate. PKG measurements in native P. falciparum proteins
were performed using an adaptation of a previously described assay
[19]. Brieﬂy, ring stage parasites were exposed to 0.15% saponin
solution in PBS to free the parasites from their host cells. Both
gametocyte and ring stage parasite pellets were lysed in HBS buffer
(50 mM Hepes [pH 7.4], 1 mM EDTA, 1% Nonidet P-40, 10 mM NaF,
0.1 mM sodium orthovanadate, 1 mM dithiotreitol) supplemented
with a 1/100 dilution of Sigma-Aldrich Protease Inhibitor Cocktail.
Parasite lysis was conﬁrmed by microscopic examination of Giemsa-
stained thin smears. Kinase reactions were carried out in 40-ll
volumes in the presence of 250 lM kemptide (LRRASLG; AnaSpec),
and 0.01 lM [32P]-ATP (3,000 Ci/mmol; GE Healthcare). The reactions
were initiated by the addition of 2 ll of lysate and incubated at 30 8C
for 45 min. Reactions were terminated and stored at 80 8C.
Radiolabelled peptide was detected on 96-well multiscreen phospho-
cellulose plates (MAPH-NOB; Millipore) by scintillation counting on
a Wallac 1450 Microbeta scintillation b-counter (Perkin-Elmer).
Native erythrocyte PKG activity present in the lysates was quantiﬁed
and did not contribute towards the observed parasite PKG activity. In
the gametocyte lysate samples, erythrocyte contamination was
between 1.1% and 2.3%. The number of rings and gametocytes were
4.9 3 107 and 5.3 3 105,, respectively. Counts were normalised by
overall protein amounts in all six fractions.
Western blotting. Recombinant protein and parasites were
prepared as described for the PKG activity assay. Protein samples
were lysed in reducing sample buffer, boiled for 10 min, run on a
10% polyacrylamide gel, and transferred to nitrocellulose membrane
according to standard procedures. Equal total protein concentrations
of all six fractions were loaded. Membranes were blocked in 2% ECL
Advance blocking powder (GE Healthcare) in Tris-buffered saline
(TBS [pH 7.6]) with 0.1% Tween 20 for 1 h according to the
manufacturer’s instructions. Blots were probed with the anti-human
PKGIa peptide antibody (C-terminal 657–671, PK10; Calbiochem) at
a concentration of 1:10,000. This antibody cross-reacts with PfPKG by
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virtue of a common C-terminal sequence motif. The antibody did not
react with uninfected human erythrocyte proteins. A HRP-conju-
gated goat anti-rabbit antiserum was used as the secondary antibody
(BioRad) at a concentration of 1:30,000. Signals were detected using
the ECL Advance chemiluminescence kit and ECL Hyperﬁlm (both
GE Healthcare) according to the manufacturer’s instructions. Bands
were quantiﬁed using ImageQuant software (Molecular Dynamics).
PDE assays. PDE activity in native parasite fractions was measured
using a modiﬁcation of a previously published method [43]. Parasites
were frozen in liquid nitrogen and stored at 80 8C until use.
Parasites were resuspended in 500 ll of lysis buffer (20 mM hepes and
250 mM sucrose [pH 7.0]), subjected to ﬁve cycles of freeze–thaw in
liquid nitrogen and pelleted at 100,000 g for 30 min. Particulate
fractions were resuspended in lysis buffer containing EDTA-free
protease inhibitors (Roche). PDE assays were carried out in triplicate
wells of a 96-well plate in the presence of [3H]-labelled cGMP (GE
Healthcare) for 30 min at 37 8C. Reactions were terminated by boiling
the plate for 1 min, followed by a 3-min centrifugation at 900 g. One
unit of alkaline phosphatase was added to each well and incubated for
30 min at 37 8C. [3H]-labelled guanosine was separated from the ra-
diolabelled cGMP substrate using ion exchange (BioRad AG 1 3 8
resin). Supernatants containing the [3H]-labelled guanosine product
were added to scintillation ﬂuid (Optiphase Supermix; Wallac).
Scintillation was measured using a Wallac 1450 Microbeta Liquid
Scintillation Counter (Perkin Elmer) and PDE activity was expressed in
picomoles cGMP/minute/milligram protein. Inhibition assays were
carried out in the presence of compounds dissolved in DMSO. PDE
assays for speciﬁc activity and IC50 determination were carried out at a
native lysate dilution that gave 30% cGMP/cAMP hydrolysis.
Supporting Information
Figure S1. Allelic Replacement of the PfPKG Gene
(A) Plasmid construct pHH1-PKG-Q/M used to mediate allelic
replacement. E, EcoRI; hDHFR, human dihydrofolate reductase
selection cassette; PbDT 39, translational termination sequences
derived from P. berghei DHFR/TS 39 untranslated region; PKG 39, an
N-terminally truncated fragment of the PfPKG coding region
containing the T618Q or the T618M substitution (star); Xb, XbaI.
Dashed line represents the plasmid backbone.
(C) Representation of the single crossover integration event that
introduced the T618Q substitution into PfPKG. The black bar
beneath depicts the position of the hDHFR probe used for Southern
analysis (lanes 1–3 on the Southern blot). Arrows show the positions
of the forward and reverse primers used to amplify then sequence
across the integration event, conﬁrming the presence of the mutated
allele. The predicted restriction fragment sizes are indicated. Black
ﬂag represents the PfPKG promoter.
(B) The WT 3D7 PfPKG locus. Introns are not shown.
(D) Representation of the single crossover integration event that
introduced the T618M substitution into PfPKG. The black bars
beneath depict the positions of the PfPKG 39 probe used for Southern
analysis (lanes 4–6 on the Southern blot).
(E) Southern blot analysis of WT and PfPKG mutants. Band sizes are
in kilobases.
Found at doi:10.1371/journal.pbio.0060139.sg001 (727 KB EPS).
Figure S2. Asexual Blood Stage Parasite Growth Is Not Impaired in
Clones Expressing the PfPKGT618Q Mutant Allele
Asexual growth of WT and PfPKGT618Q clone A and PfPKGT618Q
clone B was monitored via incorporation of [3H]-hypoxanthine and
plotted as counts per minute (cpm). Data show the means of triplicate
counts from three independent experiments, and error bars indicate
6 the standard error of the mean (SEM). In addition to the above
measurements, the relative growth of asexual parasites derived from
allelic replacement and control clones was evaluated on numerous
occasions (n . 10) prior to initiating gametocyte growth. On all
occasions, growth rates between clones were very similar, allowing
gametocytogenesis to be initiated simultaneously for subsequent
gametogenesis assays in mutants and controls.
Found at doi:10.1371/journal.pbio.0060139.sg002 (256 KB EPS).
Figure S3. Mean Rounding-Up Values for Mutant Clones and WT
Plotted against Compound 1 Concentration
Rounding up of mutant clones PfPKGT618M (21C11) and PfPKGT618Q
(4D2) compared to WT over a range of compound 1 concentrations
(0.1–20 lM). Error bars indicate 6 SEM. Data were analysed using the
Prism package (GraphPad software).
Found at doi:10.1371/journal.pbio.0060139.sg003 (724 KB EPS).
Table S1. The Effect of PDE Inhibitors on Particulate Fractions
Isolated from P. falciparum Sexual and Asexual Blood Stage Parasites
IC50 values (the concentration of compound that gave 50% inhibition
of native PDE activity) are mean 6 SEM in micromolar and were
calculated using the Prism software package (GraphPad Software).
Percentage inhibition data were ﬁtted to a sigmoidal dose-response
curve using nonlinear regression. n.d., not determined; .200,
sufﬁcient inhibition was not observed for an IC50 calculation. The
speciﬁc activity of cGMP hydrolysis measured in the individual life
cycle stages (at a substrate concentration of 0.82 lM) is listed in the
lower row. Speciﬁc activity data are mean6 SEM in picomoles cGMP/
minute/milligram.
Found at doi:10.1371/journal.pbio.0060139.st001 (43 KB DOC).
Table S2. Poisson Regression Analysis for Compound 1 Sensitivity of
Rounding Up of Both Mutants Compared to WT
Each rounding-up measurement was made by counting 200 cells and
scoring for rounding up (or not rounding up). At each compound 1
concentration, rounding-up replicate counts for both clones were
compared to WT values separately by Poisson regression analysis
using the Stata 9.2 package (StataCorp). Where n , 2 (indicated by
n.d.), data were excluded from the analysis. Compound 1 concen-
tration (comp1) is shown in micromolar. The p-values from this
analysis and the relative risk (RR) of rounding up with genetic
background (and 95% conﬁdence intervals [CI]) are shown.
Found at doi:10.1371/journal.pbio.0060139.st002 (38 KB DOC).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
ber for EtPKG is AF411961 and for TgPKG is AF413570.
The PlasmoDB (http://plasmodb.org/plasmo/) accession number for
PfPKG is PF14_0346.
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